This inventor holds 1 USPTO granted patent. Top assignee: Medigen Biotechnology Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovative Journey of Pei-Hsun Ho in Cancer Research
Introduction
Pei-Hsun Ho, an accomplished inventor based in Sinjhuang, Taiwan, has made significant strides in the field of cancer research. With a focus on understanding oncogenes, her work has led to the development of innovative methods for detecting and diagnosing cancer, potentially transforming patient care and treatment options.
Latest Patents
Pei-Hsun Ho holds a notable patent related to cancer-specific gene MH15, identified as an oncogene. This patent provides methods and compositions for detecting and diagnosing cancer by determining the level of MH15 expression in biological samples. Furthermore, it outlines approaches to screen for inhibitors and moderators of MH15 expression and activity. The innovations in her patent also include compositions that consist of compounds and molecules designed to inhibit or moderate MH15 expression or activity, thereby contributing to cancer treatment in vivo.
Career Highlights
As a key member of Medigen Biotechnology Corporation, Pei-Hsun Ho has integrated her expertise with cutting-edge research in biotechnology. Her dedication to cancer research is evident not only in her patent achievements but also in her commitment to enhancing patient outcomes through innovative therapeutic approaches.
Collaborations
Pei-Hsun Ho collaborates with esteemed colleagues, including Stanley Chang and Hsun-Lang Chang, who share her passion for advancing cancer research. These collaborations are integral to the development of effective diagnostic and therapeutic strategies, enhancing the potential impact of their collective work in the medical field.
Conclusion
Pei-Hsun Ho is a pioneering inventor whose contributions to cancer research are paving the way for improved diagnostic and treatment solutions. Through her innovative spirit and collaboration within Medigen Biotechnology Corporation, she continues to be a driving force in the fight against cancer, inspiring future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile